Literature DB >> 2170822

Pharmacokinetics of oestrogens and progestogens.

H Kuhl1.   

Abstract

There are large inter- and intra-individual variations in the serum concentrations of natural and synthetic sex steroids irrespective of the route of administration. Oral ingestion of steroids has a stronger effect on hepatic metabolism than parenteral administration, as the local concentration in liver sinusoids are 4-5 times higher during the first liver passage. Oestradiol and oestrone are interconvertible, dependent on the local concentrations in liver and target organs, and oestrone sulphate serves as a large reservoir. The oestrone/oestradiol ratio has no physiological significance, as oestrone is only a weak oestrogen. Oestrone is both a precursor and a metabolite of oestradiol. Oestriol is extensively conjugated after oral administration. Therefore, the oestriol serum levels are similar after oral intake of 10 mg and after vaginal application of 0.5 mg oestriol resulting in similar systemic effectiveness. Conjugated oestrogens can easily enter the hepatocytes but are hormonally active only after hydrolyzation into the parent steroids. Ethinylestradiol which exerts strong effects on hepatic metabolism and inhibits metabolizing enzymes, should not be used for hormone replacement therapy. Among the progestogens, the progesterone derivatives have less effects on liver metabolism than the norethisterone derivatives (13-methyl-gonanes and 13-ethyl-gonanes). The highly potent 13-ethyl-gonanes are effective at very low doses, because of a slow inactivation and elimination rate due to the ethinyl group.

Entities:  

Keywords:  Biology; Chlormadinone Acetate--pharmacodynamics; Contraception; Contraceptive Agents, Estrogen--pharmacodynamics; Contraceptive Agents, Female--pharmacodynamics; Contraceptive Agents, Progestin--pharmacodynamics; Contraceptive Agents--pharmacodynamics; Cyproterone Acetate--pharmacodynamics; Endocrine System; Estradiol--analysis; Estriol--analysis; Estrogens--pharmacodynamics; Estrone--analysis; Ethinyl Estradiol--pharmacodynamics; Ethynodiol Diacetate--pharmacodynamics; Examinations And Diagnoses; Family Planning; Hormone Antagonists; Hormones; Laboratory Examinations And Diagnoses; Levonorgestrel--pharmacodynamics; Lynestrenol--pharmacodynamics; Measurement; Metabolic Effects; Norethindrone Acetate--pharmacodynamics; Norethindrone--pharmacodynamics; Physiology; Progestational Hormones; Progesterone--pharmacodynamics; Research Methodology; Steroid Metabolic Effects

Mesh:

Substances:

Year:  1990        PMID: 2170822     DOI: 10.1016/0378-5122(90)90003-o

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  20 in total

Review 1.  Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception.

Authors:  Frank Z Stanczyk
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

Review 2.  Estradiol and dydrogesterone. A review of their combined use as hormone replacement therapy in postmenopausal women.

Authors:  R H Foster; J A Balfour
Journal:  Drugs Aging       Date:  1997-10       Impact factor: 3.923

Review 3.  Hormone replacement therapy in the aged. A state of the art review.

Authors:  S Jacobs; T C Hillard
Journal:  Drugs Aging       Date:  1996-03       Impact factor: 3.923

Review 4.  Estradiol valerate/dienogest.

Authors:  Keri Wellington; Caroline M Perry
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 5.  Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects.

Authors:  Frank Z Stanczyk; Janet P Hapgood; Sharon Winer; Daniel R Mishell
Journal:  Endocr Rev       Date:  2012-12-13       Impact factor: 19.871

6.  Low-dose 17-β-estradiol cream for vaginal atrophy in a cohort without prolapse: Serum levels and vaginal response including tissue biomarkers associated with tissue remodeling.

Authors:  Jana D Illston; Thomas L Wheeler; C Richard Parker; Michael G Conner; Kathryn L Burgio; Patricia S Goode; Holly E Richter
Journal:  Maturitas       Date:  2015-06-05       Impact factor: 4.342

7.  Pharmacokinetic evaluation of oral 17 beta-oestradiol and two different fat soluble analogues in ovariectomized women.

Authors:  W Schubert; G Cullberg; T Hedner
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  Hormone replacement therapy increases serum 1,25-dihydroxyvitamin D: A 2-year prospective study.

Authors:  H J van Hoof; M J van der Mooren; L M Swinkels; R Rolland; T J Benraad
Journal:  Calcif Tissue Int       Date:  1994-12       Impact factor: 4.333

9.  Medroxyprogesterone acetate antagonizes the effects of estrogen treatment on social and sexual behavior in female macaques.

Authors:  Karen Pazol; Mark E Wilson; Kim Wallen
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

10.  Ethinylestradiol/chlormadinone acetate.

Authors:  Monique P Curran; Antona J Wagstaff
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.